Literature DB >> 18774963

Transfusion efficacy of ABO major-mismatched platelets (PLTs) in children is inferior to that of ABO-identical PLTs.

Friedgard Julmy1, Roland A Ammann, Behrouz Mansouri Taleghani, Stefano Fontana, Andreas Hirt, Kurt Leibundgut.   

Abstract

BACKGROUND: ABO major compatibility is essential in transfusions of red blood cells but is not requisite in PLT transfusions. In adults there is some evidence that transfusion efficacy of ABO blood group-identical platelets (PLTs) is superior to major-mismatched PLTs. However, in children this question has not been investigated for more than 30 years. STUDY DESIGN AND METHODS: In a prospective study, the efficacy (based on the 1-hour percentage of PLT recovery [PPR(1hr)]) of 400 eligible ABO blood group-identical or out-of-group apheresis PLT concentrates (APCs), transfused mainly prophylactically to 50 children with hematologic malignancies, solid tumors, or aplastic anemia was investigated. The primary objective was to compare PPR(1hr) between ABO-identical and major-mismatched transfusions.
RESULTS: After ABO major-mismatched transfusions, PPR(1hr) was significantly lower than after ABO blood group-identical transfusions (median 21% vs. 32%; p = 0.034). Multivariate analysis showed major-mismatched transfusions to be significantly more often unsuccessful than identical transfusions (odds ratio [OR], 3.97; 95% confidence interval [CI], 1.52-10.39; p = 0.005). Using flow cytometry and fluorescent microscopy, it could be demonstrated that PLTs of subgroup A(1), significantly expressing A antigen on their surface, were rapidly cleared from the circulation of group O or B recipients. In contrast, major-mismatched transfusions of A(2) PLTs, expressing no detectable A antigen, were as successful as identical transfusions (OR, 1.13; 95% CI, 0.16-7.88; p = 0.90).
CONCLUSION: These data clearly indicate that in children ABO major-mismatched PLT transfusions result in inferior transfusion efficacy, with the only exception of group A(2) PLTs. ABO minor-mismatched PLTs showed comparable efficacy to identical transfusions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774963     DOI: 10.1111/j.1537-2995.2008.01914.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  13 in total

1.  The Blood Group A Genotype Determines the Level of Expression of the Blood Group A on Platelets But Not the Anti-B Isotiter.

Authors:  Barbara Lehner; Beate Eichelberger; Christof Jungbauer; Simon Panzer
Journal:  Transfus Med Hemother       Date:  2015-06-18       Impact factor: 3.747

2.  Platelet transfusion - the art and science of compromise.

Authors:  Joan Cid; Sarah K Harm; Mark H Yazer
Journal:  Transfus Med Hemother       Date:  2013-04-26       Impact factor: 3.747

3.  Effectiveness of Pooled Platelet Transfusion in Concordant and Discordant Groups among Dengue Patients.

Authors:  Amoolya Bhat; Vijaya Chowdappa; Smita Surendra Masamatti
Journal:  J Clin Diagn Res       Date:  2016-07-01

4.  Transfusion-related adverse events in the Platelet Dose study.

Authors:  Richard M Kaufman; Susan F Assmann; Darrell J Triulzi; Ronald G Strauss; Paul Ness; Suzanne Granger; Sherrill J Slichter
Journal:  Transfusion       Date:  2014-07-28       Impact factor: 3.157

5.  Transfusion of ABO non-identical platelets does not influence the clinical outcome of patients undergoing autologous haematopoietic stem cell transplantation.

Authors:  Pilar Solves; Nelly Carpio; Aitana Balaguer; Samuel Romero; Gloria Iacoboni; Inés Gómez; Ignacio Lorenzo; Federico Moscardó; Jaime Sanz; Francisca Lopez; Guillermo Martin; Isidro Jarque; Pau Montesinos; Javier De La Rubia; Guillermo Sanz; Miguel A Sanz
Journal:  Blood Transfus       Date:  2015-02-02       Impact factor: 3.443

6.  Transfusion efficacy of apheresis platelet concentrates irradiated at the day of transfusion is significantly superior compared to platelets irradiated in advance.

Authors:  Friedgard Julmy; Roland A Ammann; Stefano Fontana; Behrouz Mansouri Taleghani; Andreas Hirt; Kurt Leibundgut
Journal:  Transfus Med Hemother       Date:  2014-05-12       Impact factor: 3.747

7.  Effects of ABO Matching of Platelet Transfusions in Critically Ill Children.

Authors:  Marianne E Nellis; Ruchika Goel; Oliver Karam; Melissa M Cushing; Peter J Davis; Marie E Steiner; Marisa Tucci; Simon J Stanworth; Philip C Spinella
Journal:  Pediatr Crit Care Med       Date:  2019-02       Impact factor: 3.624

8.  Recommendations for transfusion in ABO-incompatible hematopoietic stem cell transplantation.

Authors:  Diarmaid O'Donghaile; Walter Kelley; Harvey G Klein; Willy A Flegel
Journal:  Transfusion       Date:  2012-02       Impact factor: 3.157

Review 9.  Neonatal and pediatric platelet transfusions: current concepts and controversies.

Authors:  Ravi Mangal Patel; Cassandra Josephson
Journal:  Curr Opin Hematol       Date:  2019-11       Impact factor: 3.284

Review 10.  Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.

Authors:  Lise J Estcourt; Simon J Stanworth; Carolyn Doree; Sally Hopewell; Marialena Trivella; Michael F Murphy
Journal:  Cochrane Database Syst Rev       Date:  2015-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.